Related Experiment Video
Updated: May 14, 2026
Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens
Published on: September 20, 2024
Post-market surveillance for literature on QuantiFERON TB Gold Plus: what improvements can artificial intelligence
J Reniewicz1, R Alagna2, L Kordylas1
1QIAGEN Wroclaw Sp. z o.o., Wroclaw, Poland.
Background:
Post-market surveillance (PMS) under the European Union In Vitro Diagnostic Regulation (IVDR) demands proactive, literature-based evidence, but mature assays like QuantiFERON TB Gold Plus (QFT-Plus) generate volumes of peer-reviewed and other literature that can strain manual workflows.
Methods:
We ran a comparative study of an AI-enabled literature-surveillance platform (jointly developed with Huma.ai called the Huma.ai Platform) versus manual search for QFT-Plus PMS. PubMed and PubMed Central were queried for publications in 2024; human studies published in English underwent duplicate screening and full-text appraisal. Outcomes were yield, precision, overlap/unique entries, and reviewer time.
Results:
The Huma.ai Platform retrieved 673 records, with 661 relevant to screening (98.21% precision). Manual searching retrieved 111, with 106 relevant to screening (95.50% precision): there were 103 shared and three manual-only items (metadata gaps). The Huma.ai Platform contributed 561 unique papers, 5 of which were excluded after full-text appraisal. In total, 664 articles were evaluated; no new safety signals were identified. Screening time averaged ∼16 s per article with Huma.ai Platform versus ∼60 s manually; full-text time (∼15 min per article) was similar.
Conclusion:
AI-assisted surveillance substantially increases coverage and reduces screening effort while maintaining high precision. Thus it supports efficient, reproducible PMS for QFT-Plus.
Related Concept Videos
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
02:57Real Time RT-PCR
The real-time quantification of the number of amplified products is...